PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
13-Nov-2019 Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor Conferences Protagonist Therapeutics, Inc.
13-Nov-2019 AcelRx Pharmaceuticals Announces Publication Analyzing Pooled Dosing and Efficacy Data on Sufentanil Sublingual 30 mcg Tablets AcelRx Pharmaceuticals, Inc.
13-Nov-2019 Evogene Reports Third Quarter 2019 Financial Results Evogene
13-Nov-2019 Arctoris Ltd Strengthens Senior Team to Continue the Development of its On-Demand Drug Discovery Services Arctoris
13-Nov-2019 BIO-Europe® 2019's Startup Slam Winner: Eisbach Bio EBD Group
13-Nov-2019 Arranta Bio announces the acquisition of Captozyme(TM), creating a Center of Excellence for microbiome development and clinical supply Arranta Bio
13-Nov-2019 AbbVie Prices $30 Billion of Senior Unsecured Notes AbbVie
12-Nov-2019 Tocagen Reports Third Quarter 2019 Financial Results and Business Updates Tocagen Inc.
12-Nov-2019 Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination Mylan N.V.
12-Nov-2019 DATA SHOWING POTENTIAL FOR MACHINE LEARNING TO ADVANCE UNDERSTANDING OF NONALCOHOLIC STEATOHEPATITIS (NASH) PRESENTED AT THE LIVER MEETING® 2019 Gilead Sciences
12-Nov-2019 GILEAD ANNOUNCES NEW DATA FROM VIRAL HEPATITIS RESEARCH PROGRAMMES AT THE LIVER MEETING® 2019 Gilead Sciences
12-Nov-2019 Key Reasons to attend SMi’s 3D Cell Culture Conference 2020 SMi Group
12-Nov-2019 HERMES PHARMA Achieves Top Rating for Sustainability Performance from EcoVadis HERMES PHARMA
12-Nov-2019 Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication Neurovalens
12-Nov-2019 Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia Minoryx Therapeutics
12-Nov-2019 Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium (SMC) for the treatment of patients with the most common form of advanced breast cancer Novartis
12-Nov-2019 New Celltrion data presented at ACR for subcutaneous formulation of CT-P13 (biosimilar infliximab) in RA Celltrion Healthcare
12-Nov-2019 Parkinson’s Foundation grants £200,000 to Parkinson’s UK to invest in the Parkinson’s Virtual Biotech Parkinson’s Foundation
12-Nov-2019 Sosei Heptares Operational Highlights and Consolidated Results for the Nine Months Ended 30 September, 2019 Sosei Heptares
11-Nov-2019 Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics Cohen Veterans Bioscience